Biotech Distilled

Substack ↗ Subscribe

Subscribe Substack ↗ About

Research Areas Modalities Phases Targets Track record Movers

Home › Targets › FGFR1

FGFR1 (1 companies · 1 programs)

Companies with an active program directed at FGFR1.

Tyra Biosciences, Inc. TYRA

TYRA-200 — Intrahepatic Cholangiocarcinoma Phase 1

Track record About Feedback Report a bug Substack ↗

This website is an encyclopedia of clinical-stage biotech companies, refreshed weekly. For informational and educational use only — not investment advice. Always verify against primary sources before making decisions.